Additionally, the utilization of lipid-lowering medication was linked to a diminished risk of CRP occurrence within this population, whereas a baseline diagnosis of DM was associated with an increased risk of CRP onset, as indicated by HR values and cumulative occurrence curve representations (Table 3, Supplementary Table 2; Figures 2D, E, 3D, E). This evidence concerns the gene CRP and diabetes mellitus.